🇺🇸 Nabilone, flexible dosing in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Nabilone, flexible dosing on 26 December 1985

Marketing authorisation

FDA — authorised 26 December 1985

Application: NDA018677
Marketing authorisation holder: BAUSCH
Local brand name: CESAMET
Indication: CAPSULE — ORAL
Status: approved

Read official source →

Frequently asked questions

Is Nabilone, flexible dosing approved in United States?

Yes. FDA authorised it on 26 December 1985.

Who is the marketing authorisation holder for Nabilone, flexible dosing in United States?

BAUSCH holds the US marketing authorisation.